SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Madrigal Pharmaceuticals
An SI Board Since April 2018
Posts SubjectMarks Bans Symbol
138 9 0 MDGL
Emcee:  Lynn Type:  Moderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
13BUZZ-Madrigal Pharma capitalizes on strong NASH data; Viking Therapeutics rides Lynn-6/7/2018
12BRIEF-Madrigal Pharmaceuticals Announces Proposed Public Offering Of Common StocLynn-6/5/2018
11From 2 June 2018: 3 Biotech Stocks That Soared This Week: Are They Buys? Keith Lynn-6/5/2018
10Upcoming events, from a CFRA Quantitative Stock Report over at ML on MDGL. Not rLynn-6/3/2018
9Better Know Biotech: 2 Stocks You've Got to Know About Lynn-6/1/2018
8Benzinga Pro's 5 Stocks To Watch Today Jayson Derrick , Benzinga StaffLynn-6/1/2018
7 H.C. Wainwright boosted the price target for Madrigal Pharmaceuticals, Inc.MDLynn-6/1/2018
6Closing price for Thursday, 31 May 2018: [graphic]Lynn-6/1/2018
5For historic purposes, here's a photo taken this morning of a page showing WLynn-6/1/2018
4Up over 140% so far today, and still climbing. After the market closes I am goinLynn-5/31/2018
3Madrigal’s MGL-3196 Achieves Liver Biopsy Endpoints in Patients with Non-alcohoLynn-5/31/2018
24 Top Stocks for Investing in Pharma's Next $35 Billion Market Lynn-4/13/2018
1Goldman Sachs: Madrigal Pharma Has Blockbuster Potential In Liver, Cholesterol TLynn-4/13/2018
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):